Indicator type;Branch of activity;Total
Number of companies carrying out R&D in Biotechnology;Total companies;1.444
Number of companies carrying out R&D in Biotechnology;Services;107
Number of companies carrying out R&D in Biotechnology;Industry and Construction;455
Number of companies carrying out R&D in Biotechnology;Agriculture;883
% Companies by type of biotechnology used: Genetic Code;Total companies;30,7
% Companies by type of biotechnology used: Genetic Code;Services;21,5
% Companies by type of biotechnology used: Genetic Code;Industry and Construction;16,8
% Companies by type of biotechnology used: Genetic Code;Agriculture;38,9
% Companies by type of biotechnology used: Functional Units;Total companies;37,6
% Companies by type of biotechnology used: Functional Units;Services;18,7
% Companies by type of biotechnology used: Functional Units;Industry and Construction;33,2
% Companies by type of biotechnology used: Functional Units;Agriculture;42,1
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Total companies;21,3
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Services;15,6
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Industry and Construction;15,1
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Agriculture;25,2
% Companies by type of biotechnology used: Bioprocesses;Total companies;50,9
% Companies by type of biotechnology used: Bioprocesses;Services;47,5
% Companies by type of biotechnology used: Bioprocesses;Industry and Construction;75,7
% Companies by type of biotechnology used: Bioprocesses;Agriculture;38,6
% Companies by type of biotechnology used: Subcellular Organisms;Total companies;8,1
% Companies by type of biotechnology used: Subcellular Organisms;Services;0,9
% Companies by type of biotechnology used: Subcellular Organisms;Industry and Construction;6,6
% Companies by type of biotechnology used: Subcellular Organisms;Agriculture;9,7
% Companies by type of biotechnology used: Bioinformatics;Total companies;22,6
% Companies by type of biotechnology used: Bioinformatics;Services;4,7
% Companies by type of biotechnology used: Bioinformatics;Industry and Construction;10,2
% Companies by type of biotechnology used: Bioinformatics;Agriculture;31,2
% Companies by type of biotechnology used: Nanobiotechnology;Total companies;9,8
% Companies by type of biotechnology used: Nanobiotechnology;Services;0,9
% Companies by type of biotechnology used: Nanobiotechnology;Industry and Construction;5,1
% Companies by type of biotechnology used: Nanobiotechnology;Agriculture;13,3
% Companies by type of biotechnology used: Other;Total companies;16,9
% Companies by type of biotechnology used: Other;Services;29,6
% Companies by type of biotechnology used: Other;Industry and Construction;9,8
% Companies by type of biotechnology used: Other;Agriculture;19
Companies in which biotechnology activities are: Main and/or exclusive;Total companies;629
Companies in which biotechnology activities are: Main and/or exclusive;Services;20
Companies in which biotechnology activities are: Main and/or exclusive;Industry and Construction;111
Companies in which biotechnology activities are: Main and/or exclusive;Agriculture;498
Companies in which biotechnology activities are: A secondary business line;Total companies;262
Companies in which biotechnology activities are: A secondary business line;Services;17
Companies in which biotechnology activities are: A secondary business line;Industry and Construction;100
Companies in which biotechnology activities are: A secondary business line;Agriculture;145
Companies in which biotechnology activities are: A necessary tool for production;Total companies;553
Companies in which biotechnology activities are: A necessary tool for production;Services;70
Companies in which biotechnology activities are: A necessary tool for production;Industry and Construction;243
Companies in which biotechnology activities are: A necessary tool for production;Agriculture;240
% Companies by final application areas of biotechnology use: Human Health;Total companies;44,3
% Companies by final application areas of biotechnology use: Human Health;Services;1,9
% Companies by final application areas of biotechnology use: Human Health;Industry and Construction;24,5
% Companies by final application areas of biotechnology use: Human Health;Agriculture;59,6
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Total companies;15,8
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Services;17,9
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Industry and Construction;13,2
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Agriculture;16,9
% Companies by final application areas of biotechnology use: Food Products;Total companies;30,7
% Companies by final application areas of biotechnology use: Food Products;Services;30,9
% Companies by final application areas of biotechnology use: Food Products;Industry and Construction;48,3
% Companies by final application areas of biotechnology use: Food Products;Agriculture;21,6
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Total companies;24,9
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Services;65,7
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Industry and Construction;22,2
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Agriculture;21,4
% Companies by final application areas of biotechnology use: Environment;Total companies;16,9
% Companies by final application areas of biotechnology use: Environment;Services;13,2
% Companies by final application areas of biotechnology use: Environment;Industry and Construction;17,2
% Companies by final application areas of biotechnology use: Environment;Agriculture;17,2
% Companies by final application areas of biotechnology use: Industry;Total companies;12,6
% Companies by final application areas of biotechnology use: Industry;Services;6,3
% Companies by final application areas of biotechnology use: Industry;Industry and Construction;13
% Companies by final application areas of biotechnology use: Industry;Agriculture;13,1
R&D personnel in Biotechnology (PP);Total companies;17.743
R&D personnel in Biotechnology (PP);Services;1.000
R&D personnel in Biotechnology (PP);Industry and Construction;5.585
R&D personnel in Biotechnology (PP);Agriculture;11.158
R&D personnel in Biotechnology (PP): Research personnel;Total companies;9.445
R&D personnel in Biotechnology (PP): Research personnel;Services;293
R&D personnel in Biotechnology (PP): Research personnel;Industry and Construction;2.218
R&D personnel in Biotechnology (PP): Research personnel;Agriculture;6.934
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Total companies;8.298
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Services;708
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Industry and Construction;3.367
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Agriculture;4.224
R&D personnel in Biotechnology (PP). Women;Total companies;9.907
R&D personnel in Biotechnology (PP). Women;Services;356
R&D personnel in Biotechnology (PP). Women;Industry and Construction;3.102
R&D personnel in Biotechnology (PP). Women;Agriculture;6.449
R&D personnel in Biotechnology (PP). Women: Research personnel;Total companies;5.104
R&D personnel in Biotechnology (PP). Women: Research personnel;Services;113
R&D personnel in Biotechnology (PP). Women: Research personnel;Industry and Construction;1.155
R&D personnel in Biotechnology (PP). Women: Research personnel;Agriculture;3.836
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Total companies;4.802
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Services;243
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Industry and Construction;1.946
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Agriculture;2.613
R&D personnel in Biotechnology (FTE);Total companies;12.993,4
R&D personnel in Biotechnology (FTE);Services;616,8
R&D personnel in Biotechnology (FTE);Industry and Construction;3.924,1
R&D personnel in Biotechnology (FTE);Agriculture;8.452,5
R&D personnel in Biotechnology (FTE): Research personnel;Total companies;7.069,9
R&D personnel in Biotechnology (FTE): Research personnel;Services;194,7
R&D personnel in Biotechnology (FTE): Research personnel;Industry and Construction;1.616
R&D personnel in Biotechnology (FTE): Research personnel;Agriculture;5.259,3
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Total companies;5.923,6
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Services;422,1
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Industry and Construction;2.308,1
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Agriculture;3.193,3
R&D personnel in Biotechnology (FTE). Women;Total companies;7.471,8
R&D personnel in Biotechnology (FTE). Women;Services;223,8
R&D personnel in Biotechnology (FTE). Women;Industry and Construction;2.336,7
R&D personnel in Biotechnology (FTE). Women;Agriculture;4.911,2
R&D personnel in Biotechnology (FTE). Women: Research personnel;Total companies;3.870,1
R&D personnel in Biotechnology (FTE). Women: Research personnel;Services;73,4
R&D personnel in Biotechnology (FTE). Women: Research personnel;Industry and Construction;894
R&D personnel in Biotechnology (FTE). Women: Research personnel;Agriculture;2.902,8
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Total companies;3.601,6
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Services;150,5
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Industry and Construction;1.442,8
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Agriculture;2.008,4
Expenditure on internal R&D in Biotechnology (thousands of euros);Total companies;1.223.801
Expenditure on internal R&D in Biotechnology (thousands of euros);Services;36.807
Expenditure on internal R&D in Biotechnology (thousands of euros);Industry and Construction;437.823
Expenditure on internal R&D in Biotechnology (thousands of euros);Agriculture;749.171
1) By type of expenditure: Current expenditure;Total companies;1.108.189
1) By type of expenditure: Current expenditure;Services;33.108
1) By type of expenditure: Current expenditure;Industry and Construction;406.903
1) By type of expenditure: Current expenditure;Agriculture;668.179
1.1) Labour expenditure of research personnel;Total companies;360.922
1.1) Labour expenditure of research personnel;Services;9.392
1.1) Labour expenditure of research personnel;Industry and Construction;108.070
1.1) Labour expenditure of research personnel;Agriculture;243.460
1.2) Labour expenditure of technical and auxiliary personnel;Total companies;220.540
1.2) Labour expenditure of technical and auxiliary personnel;Services;11.866
1.2) Labour expenditure of technical and auxiliary personnel;Industry and Construction;91.401
1.2) Labour expenditure of technical and auxiliary personnel;Agriculture;117.272
1.3) Other current expenditure;Total companies;526.727
1.3) Other current expenditure;Services;11.849
1.3) Other current expenditure;Industry and Construction;207.432
1.3) Other current expenditure;Agriculture;307.446
2) By type of expenditure: Capital expenditure;Total companies;115.612
2) By type of expenditure: Capital expenditure;Services;3.699
2) By type of expenditure: Capital expenditure;Industry and Construction;30.921
2) By type of expenditure: Capital expenditure;Agriculture;80.993
2.1) Land and buildings;Total companies;16.843
2.1) Land and buildings;Services;1.812
2.1) Land and buildings;Industry and Construction;2.957
2.1) Land and buildings;Agriculture;12.074
2.2) Equipment and tools;Total companies;63.527
2.2) Equipment and tools;Services;1.809
2.2) Equipment and tools;Industry and Construction;22.909
2.2) Equipment and tools;Agriculture;38.809
2.3) Acquisition of specific R&D software;Total companies;3.959
2.3) Acquisition of specific R&D software;Services;61
2.3) Acquisition of specific R&D software;Industry and Construction;841
2.3) Acquisition of specific R&D software;Agriculture;3.057
2.4) Other R&D-specific IP products;Total companies;31.284
2.4) Other R&D-specific IP products;Services;17
2.4) Other R&D-specific IP products;Industry and Construction;4.214
2.4) Other R&D-specific IP products;Agriculture;27.054
1.1) By origin of funds: Own funds;Total companies;860.603
1.1) By origin of funds: Own funds;Services;34.837
1.1) By origin of funds: Own funds;Industry and Construction;371.804
1.1) By origin of funds: Own funds;Agriculture;453.963
1.2) By origin of funds: Funds from the Business sector;Total companies;128.002
1.2) By origin of funds: Funds from the Business sector;Services;84
1.2) By origin of funds: Funds from the Business sector;Industry and Construction;5.242
1.2) By origin of funds: Funds from the Business sector;Agriculture;122.675
1.3) By origin of funds: Funds from the Public Administration sector;Total companies;119.498
1.3) By origin of funds: Funds from the Public Administration sector;Services;1.832
1.3) By origin of funds: Funds from the Public Administration sector;Industry and Construction;17.353
1.3) By origin of funds: Funds from the Public Administration sector;Agriculture;100.313
1.4) By origin of funds: Funds from the Higher Education sector;Total companies;647
1.4) By origin of funds: Funds from the Higher Education sector;Services;0
1.4) By origin of funds: Funds from the Higher Education sector;Industry and Construction;9
1.4) By origin of funds: Funds from the Higher Education sector;Agriculture;638
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Total companies;12.986
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Services;0
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Industry and Construction;19
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Agriculture;12.966
1.6) By origin of funds: Funds from the rest of the world;Total companies;102.065
1.6) By origin of funds: Funds from the rest of the world;Services;54
1.6) By origin of funds: Funds from the rest of the world;Industry and Construction;43.395
1.6) By origin of funds: Funds from the rest of the world;Agriculture;58.617
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Total companies;123.396
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Services;775
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Industry and Construction;74.871
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Agriculture;47.750
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Total companies;88.985
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Services;775
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Industry and Construction;63.502
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Agriculture;24.707
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Total companies;34.412
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Services;0
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Industry and Construction;11.368
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Agriculture;23.043
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Total companies;39,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Services;31,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Industry and Construction;28,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Agriculture;46,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Total companies;15,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Services;15,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Industry and Construction;18,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Agriculture;13,6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Total companies;22,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Services;24,6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Industry and Construction;20,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Agriculture;22,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Total companies;12,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Services;8,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Industry and Construction;11,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Agriculture;12,9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Total companies;17,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Services;8,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Industry and Construction;12,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Agriculture;20,7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Total companies;17,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Services;11
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Industry and Construction;14,6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Agriculture;20,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Total companies;16
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Services;14,9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Industry and Construction;16,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Agriculture;15,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Total companies;41,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Services;49
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Industry and Construction;39,6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Agriculture;41,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Total companies;50,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Services;51,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Industry and Construction;50,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Agriculture;50
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Total companies;20,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Services;25,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Industry and Construction;17,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Agriculture;20,9
% Companies with international revenues related to biotechnology activities;Total companies;22,7
% Companies with international revenues related to biotechnology activities;Services;8,1
% Companies with international revenues related to biotechnology activities;Industry and Construction;22,3
% Companies with international revenues related to biotechnology activities;Agriculture;24,7
% Companies representing international revenues related to biotechnology activities;Total companies;2,1
% Companies representing international revenues related to biotechnology activities;Services;4,6
% Companies representing international revenues related to biotechnology activities;Industry and Construction;1,9
% Companies representing international revenues related to biotechnology activities;Agriculture;3,5
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Total companies;60,6
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Services;88,4
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Industry and Construction;63
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Agriculture;46,9
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Total companies;39,4
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Services;11,6
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Industry and Construction;37
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Agriculture;53,1
% International revenues related to biotechnology activities by classification: International trade in goods and services;Total companies;87,8
% International revenues related to biotechnology activities by classification: International trade in goods and services;Services;100
% International revenues related to biotechnology activities by classification: International trade in goods and services;Industry and Construction;88,6
% International revenues related to biotechnology activities by classification: International trade in goods and services;Agriculture;82,7
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total companies;10,1
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Services;0
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Industry and Construction;10,7
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Agriculture;8,8
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Total companies;1,4
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Services;0
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Industry and Construction;0,6
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Agriculture;4,9
% International revenues related to biotechnology activities by classification: Other;Total companies;0,8
% International revenues related to biotechnology activities by classification: Other;Services;0
% International revenues related to biotechnology activities by classification: Other;Industry and Construction;0,1
% International revenues related to biotechnology activities by classification: Other;Agriculture;3,6